Activities of Faropenem, an Oral β-Lactam, against Recent U.S. Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

The in vitro activities of faropenem and other antimicrobial agents were determined against 4,725 Streptococcus pneumoniae isolates, 2,614 Haemophilus influenzae isolates, and 1,193 Moraxella catarrhalis isolates collected from 273 U.S. laboratories during 1999. Faropenem MICs at which 90% of isolat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Critchley, Ian A., Karlowsky, James A., Draghi, Deborah C., Jones, Mark E., Thornsberry, Clyde, Murfitt, Kate, Sahm, Daniel F.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2002
Matèries:
Susceptibility
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC127058/
https://ncbi.nlm.nih.gov/pubmed/11796376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.2.550-555.2002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars